Tilray | TRLY - Market Capitalization

Stock Price
9.51
Daily Change
0.07 0.74%
Monthly
-8.65%
Yearly
890.63%
Q1 Forecast
9.24

Tilray reported $7.29B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 781.35M 426.11M Sep/2025
Cronos Group USD 1B 55.93M Dec/2025
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Knight Therapeutics CAD 624.22M 38.25M Mar/2026
Organigram Holdings CAD 378.8M 132.2M Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025
Zealand Pharma A/S 33.35B 0 Feb/2026